{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:20:49Z","timestamp":1790486449360,"version":"4.1.0"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T00:00:00Z","timestamp":1548374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The prevalence of azole-resistant Aspergillus fumigatus (ARAF) in Japan is unclear. We aimed to investigate the epidemiology of clinically isolated Aspergillus species and the frequency of azole resistance in Aspergillus species, particularly Aspergillus fumigatus, in the Kyoto and Shiga regions of Japan. Strains of clinically isolated Aspergillus species were prospectively collected from nine acute care hospitals. Species identification was performed by DNA sequence analysis, and all strains were subjected to antifungal susceptibility testing. Sequencing of the Aspergillus cyp51A gene and promoter region and genotyping by short tandem repeats were performed for ARAF isolates. A total of 149 strains were collected, and 130 strains were included for the subsequent analysis after the exclusion of duplicate isolates. The most commonly isolated species was Aspergillus fumigatus, accounting for 43.1% (56 isolates) overall, and seven (12.7%) of 55 strains of A. fumigatus were azole-resistant. Azole-resistance of other Aspergillus species were also found that two (22.2%) of nine strains of A. tubingensis and two (28.6%) of seven strains of A. flavus were azole-resistant. DNA sequence analysis of the ARAF strains revealed that two carried the cyp51A TR34\/L98H mutation, one carried G448S, one carried M220I, and three had no relevant mutations (wild type). Genotyping and phylogenetic analyses showed that the TR34\/L98H strains were clustered with the strains from the Netherlands and France. These data suggest the emergence of ARAF with TR34\/L98H in Japan, and continuous surveillance will be important to identify trends in resistance.<\/jats:p>","DOI":"10.1093\/mmy\/myz003","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T07:10:58Z","timestamp":1547104258000},"page":"997-1003","source":"Crossref","is-referenced-by-count":39,"title":["Prospective multicenter surveillance of clinically isolated Aspergillus species revealed azole-resistant Aspergillus fumigatus isolates with TR34\/L98H mutation in the Kyoto and Shiga regions of Japan"],"prefix":"10.1093","volume":"57","author":[{"given":"Yasuhiro","family":"Tsuchido","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8595-8944","authenticated-orcid":false,"given":"Yasufumi","family":"Matsumura","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Nagao","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,1,25]]},"reference":[{"key":"2019100313120594000_bib1","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMra0808853","article-title":"Aspergillosis","volume":"360","author":"Segal","year":"2009","journal-title":"N Engl J Med"},{"key":"2019100313120594000_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 Update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2019100313120594000_bib3","doi-asserted-by":"crossref","first-page":"S436","DOI":"10.1093\/infdis\/jix210","article-title":"Azole-resistant aspergillosis: epidemiology, molecular mechanisms, and treatment","volume":"216","author":"Chowdhary","year":"2017","journal-title":"J Infect Dis"},{"key":"2019100313120594000_bib4","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/AAC.41.6.1364","article-title":"Itraconazole resistance in Aspergillus fumigatus","volume":"41","author":"Denning","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"2019100313120594000_bib5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3389\/fmicb.2016.00683","article-title":"Aspergillus fumigatus-related species in clinical practice","volume":"7","author":"Lamoth","year":"2016","journal-title":"Front Microbiol"},{"key":"2019100313120594000_bib6","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1128\/AAC.01092-06","article-title":"A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations","volume":"51","author":"Mellado","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2019100313120594000_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.fgb.2015.06.001","article-title":"Genotype-phenotype complexity of the TR46\/Y121F\/T289A cyp51A azole resistance mechanism in Aspergillus fumigatus","volume":"82","author":"Snelders","year":"2015","journal-title":"Fungal Genet Biol"},{"key":"2019100313120594000_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13693780802545600","article-title":"Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery","volume":"47","author":"Hodiamont","year":"2009","journal-title":"Med Mycol"},{"key":"2019100313120594000_bib9","doi-asserted-by":"crossref","first-page":"e00791","DOI":"10.1128\/mBio.00791-17","article-title":"A novel environmental azole resistance mutation in Aspergillus fumigatus and a possible role of sexual reproduction in its emergence","volume":"8","author":"Zhang","year":"2017","journal-title":"MBio"},{"key":"2019100313120594000_bib10","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/AAC.05394-11","article-title":"Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan","volume":"56","author":"Tashiro","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2019100313120594000_bib11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jiac.2016.01.015","article-title":"Multi-azole resistant Aspergillus fumigatus harboring Cyp51A TR46\/Y121F\/T289A isolated in Japan","volume":"22","author":"Hagiwara","year":"2016","journal-title":"J Infect Chemother"},{"key":"2019100313120594000_bib12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jiac.2016.12.004","article-title":"First clinical isolation report of azole-resistant Aspergillus fumigatus with TR34\/L98H-type mutation in Japan","volume":"23","author":"Toyotome","year":"2017","journal-title":"J Infect Chemother"},{"key":"2019100313120594000_bib13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.simyco.2014.07.004","article-title":"Phylogeny, identification and nomenclature of the genus Aspergillus","volume":"78","author":"Samson","year":"2014","journal-title":"Stud Mycol"},{"key":"2019100313120594000_bib14","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi","author":"Clinical and Laboratory Standards Institute","year":"2017","edition":"Third Edition"},{"key":"2019100313120594000_bib15","first-page":"429","article-title":"Prevalence of azole-resistant Aspergillus fumigatus in the environment of Thailand","volume":"55","author":"Tangwattanachuleeporn","year":"2017","journal-title":"Med Mycol"},{"key":"2019100313120594000_bib16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.mimet.2009.03.004","article-title":"Utility of CSP typing to sub-type clinical Aspergillus fumigatus isolates and proposal for a new CSP type nomenclature","volume":"77","author":"Klaassen","year":"2009","journal-title":"J Microbiol Methods"},{"key":"2019100313120594000_bib17","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1128\/JCM.43.8.4112-4120.2005","article-title":"Use of a novel panel of nine short tandem repeats for exact and high-resolution fingerprinting of Aspergillus fumigatus isolates","volume":"43","author":"de Valk","year":"2005","journal-title":"J Clin Microbiol"},{"key":"2019100313120594000_bib18","doi-asserted-by":"crossref","first-page":"e01549","DOI":"10.1128\/AAC.01549-17","article-title":"Elevated MIC values of imidazole drugs against Aspergillus fumigatus isolates with TR34","volume":"62","author":"Chen","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2019100313120594000_bib19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/cid\/ciw664","article-title":"Home environment as a source of life-threatening azole-resistant Aspergillus fumigatus in immunocompromised patients","volume":"64","author":"Lavergne","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2019100313120594000_bib20","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1128\/JCM.00213-11","article-title":"Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance","volume":"49","author":"Mortensen","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2019100313120594000_bib21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/jac\/dku410","article-title":"Concomitant occurrence of itraconazole-resistant and -susceptible strains of Aspergillus fumigatus in routine cultures","volume":"70","author":"Ahmad","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2019100313120594000_bib22","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1128\/JCM.01105-14","article-title":"Whole-genome comparison of Aspergillus fumigatus strains serially isolated from patients with aspergillosis","volume":"52","author":"Hagiwara","year":"2014","journal-title":"J Clin Microbiol"},{"key":"2019100313120594000_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.envres.2014.05.009","article-title":"Occurrence of triazole-resistant Aspergillus fumigatus with TR34","volume":"133","author":"Ahmad","year":"2014","journal-title":"Environ Res"},{"key":"2019100313120594000_bib24","doi-asserted-by":"crossref","first-page":"45631","DOI":"10.1038\/srep45631","article-title":"Azole-resistant Aspergillus fumigatus harboring TR34","volume":"7","author":"Alvarez-Moreno","year":"2017","journal-title":"Sci Rep"},{"key":"2019100313120594000_bib25","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/myc.12089","article-title":"Environmental study of azole-resistant Aspergillus fumigatus with TR34","volume":"56","author":"Badali","year":"2013","journal-title":"Mycoses"},{"key":"2019100313120594000_bib26","doi-asserted-by":"crossref","first-page":"e52871","DOI":"10.1371\/journal.pone.0052871","article-title":"Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR34","volume":"7","author":"Chowdhary","year":"2012","journal-title":"PLoS One"},{"key":"2019100313120594000_bib27","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.diagmicrobio.2012.06.030","article-title":"In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus","volume":"74","author":"Krishnan Natesan","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2019100313120594000_bib28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/JCM.02478-15","article-title":"First detection of TR34 L98H and TR46 Y121F T289A Cyp51 mutations in Aspergillus fumigatus isolates in the United States","volume":"54","author":"Wiederhold","year":"2016","journal-title":"J Clin Microbiol"},{"key":"2019100313120594000_bib29","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1128\/AAC.47.3.1120-1124.2003","article-title":"A point mutation in the 14alpha-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus","volume":"47","author":"Diaz-Guerra","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2019100313120594000_bib30","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure","volume":"15","author":"Howard","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"2019100313120594000_bib31","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1128\/AAC.01005-16","article-title":"Epidemiology and molecular characterizations of azole resistance in clinical and environmental Aspergillus fumigatus isolates from China","volume":"60","author":"Chen","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2019100313120594000_bib32","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/myc.12324","article-title":"Multi-triazole-resistant Aspergillus fumigatus infections in Australia","volume":"58","author":"Kidd","year":"2015","journal-title":"Mycoses"},{"key":"2019100313120594000_bib33","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ijantimicag.2006.08.017","article-title":"Multi-azole resistance in Aspergillus fumigatus","volume":"28","author":"Howard","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"2019100313120594000_bib34","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1128\/AAC.01599-09","article-title":"Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling","volume":"54","author":"Snelders","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2019100313120594000_bib35","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1371\/journal.pmed.0050219","article-title":"Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism","volume":"5","author":"Snelders","year":"2008","journal-title":"PLoS Med"},{"key":"2019100313120594000_bib36","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1128\/AAC.00233-15","article-title":"Nationwide surveillance of azole resistance in Aspergillus diseases","volume":"59","author":"Vermeulen","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2019100313120594000_bib37","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/mmy\/myv029","article-title":"Prospective evaluation of azole resistance in Aspergillus fumigatus clinical isolates in France","volume":"53","author":"Choukri","year":"2015","journal-title":"Med Mycol"},{"key":"2019100313120594000_bib38","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1128\/AAC.00167-13","article-title":"cyp51A-based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany","volume":"57","author":"Bader","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2019100313120594000_bib39","doi-asserted-by":"crossref","first-page":"e00358","DOI":"10.1128\/AAC.00358-18","article-title":"Molecular identification and susceptibility testing of molds isolated in a prospective surveillance of triazole resistance in Spain (FILPOP2 study)","volume":"62","author":"Alastruey-Izquierdo","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2019100313120594000_bib40","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/AAC.00383-13","article-title":"Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study)","volume":"57","author":"Alastruey-Izquierdo","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2019100313120594000_bib41","doi-asserted-by":"crossref","first-page":"570.e1","DOI":"10.1016\/j.cmi.2016.04.001","article-title":"Azole-resistant Aspergillus fumigatus in Denmark: a laboratory-based study on resistance mechanisms and genotypes","volume":"22","author":"Jensen","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2019100313120594000_bib42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/mmy\/myx012","article-title":"Detection of Polish clinical Aspergillus fumigatus isolates resistant to triazoles","volume":"56","author":"Nawrot","year":"2018","journal-title":"Med Mycol"},{"key":"2019100313120594000_bib43","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jiac.2015.04.012","article-title":"First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34\/L98H mutations in Turkey","volume":"21","author":"\u00d6zmerdiven","year":"2015","journal-title":"J Infect Chemother"},{"key":"2019100313120594000_bib44","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/myc.12354","article-title":"Azole-resistant Aspergillus fumigatus isolates carrying TR34\/L98H mutations in Taiwan","volume":"58","author":"Wu","year":"2015","journal-title":"Mycoses"},{"key":"2019100313120594000_bib45","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3389\/fmicb.2015.00428","article-title":"Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia","volume":"6","author":"Chowdhary","year":"2015","journal-title":"Front Microbiol"},{"key":"2019100313120594000_bib46","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1093\/jac\/dky187","article-title":"Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates","volume":"73","author":"Talbot","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2019100313120594000_bib47","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/myc.12759","article-title":"Surveillance for azoles resistance in Aspergillus spp. highlights a high number of amphotericin B-resistant isolates","volume":"61","author":"Reichert-Lima","year":"2018","journal-title":"Mycoses"},{"key":"2019100313120594000_bib48","doi-asserted-by":"crossref","first-page":"e02240","DOI":"10.1128\/AAC.02240-17","article-title":"Detection of TR34\/L98H CYP51A mutation through passive surveillance for azole-resistant Aspergillus fumigatus in the United States from 2015 to 2017","volume":"62","author":"Berkow","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2019100313120594000_bib49","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3389\/fmicb.2018.00531","article-title":"Performance of molecular approaches for Aspergillus detection and azole resistance surveillance in cystic fibrosis","volume":"9","author":"Guegan","year":"2018","journal-title":"Front Microbiol"},{"key":"2019100313120594000_bib50","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/jac\/dkv177","article-title":"High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients","volume":"70","author":"Fuhren","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2019100313120594000_bib51","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/jac\/dku566","article-title":"Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany","volume":"70","author":"Steinmann","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2019100313120594000_bib52","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jinf.2017.11.011","article-title":"Improving the diagnosis of invasive aspergillosis by the detection of Aspergillus in broncho-alveolar lavage fluid: Comparison of non-culture-based assays","volume":"76","author":"Guegan","year":"2018","journal-title":"J Infect"},{"key":"2019100313120594000_bib53","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3389\/fmicb.2016.01382","article-title":"Epidemiological and genomic landscape of azole resistance mechanisms in Aspergillus fungi","volume":"7","author":"Hagiwara","year":"2016","journal-title":"Front Microbiol"},{"key":"2019100313120594000_bib54","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.3201\/eid2410.180730","article-title":"Non-cyp51A azole-resistant Aspergillus fumigatus isolates with mutation in HMG-CoA Reductase","volume":"24","author":"Hagiwara","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2019100313120594000_bib55","doi-asserted-by":"crossref","first-page":"e02583","DOI":"10.1128\/AAC.02583-16","article-title":"Drug sensitivity and resistance mechanism in Aspergillus section Nigri strain from Japan","volume":"61","author":"Hashimoto","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2019100313120594000_bib56","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1128\/AAC.00637-15","article-title":"A novel Y319H substitution in CYP51C associated with azole resistance in Aspergillus flavus","volume":"59","author":"Paul","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2019100313120594000_bib57","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.diagmicrobio.2013.04.022","article-title":"Differential expression of ATP-binding cassette and\/or major facilitator superfamily class efflux pumps contributes to voriconazole resistance in Aspergillus flavus","volume":"76","author":"Natesan","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2019100313120594000_bib58","doi-asserted-by":"crossref","first-page":"e01216","DOI":"10.1128\/AAC.01216-18","article-title":"Contributions of yap1 mutation and subsequent atrF upregulation to voriconazole resistance in Aspergillus flavus","volume":"62","author":"Ukai","year":"2018","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/57\/8\/997\/30098500\/myz003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T13:12:40Z","timestamp":1570108360000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/57\/8\/997\/5300208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,25]]},"references-count":58,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,1,25]]},"published-print":{"date-parts":[[2019,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myz003","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11]]},"published":{"date-parts":[[2019,1,25]]}}}